C - Chemistry – Metallurgy – 12 – P
Patent
C - Chemistry, Metallurgy
12
P
C12P 19/34 (2006.01) C07H 21/04 (2006.01) C12Q 1/68 (2006.01)
Patent
CA 2496003
The present invention involves the use of quantitative RT-PCR to identify AC133 as a marker. AC133 is prevalent on endothelial progenitor cells (EPCs), which are important cells in angiogenesis. Therefore, the invention is applied to ascertain the quantity of EPCs in a subject, and to diagnose and monitor angiogenesis, for example, in injured tissues and in cancer development and progression.
L'invention concerne l'utilisation de RT-PCR quantitative pour identifier AC133 comme marqueur. AC133 est courant sur les cellules souches endothéliales (EPC), qui jouent un rôle important dans l'angiogénèse. La présente invention concerne donc la détermination de la quantité d'EPC chez un sujet, ainsi que le diagnostic et la surveillance de l'angiogénèse, par exemple, dans des tissus blessés et dans le développement d'un cancer.
Lin Edward H.
Wu Xifeng
Xie Keping
Board Of Regents The University Of Texas System
Kirby Eades Gale Baker
LandOfFree
Quantitative rt-pcr to ac133 to diagnose cancer and monitor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quantitative rt-pcr to ac133 to diagnose cancer and monitor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quantitative rt-pcr to ac133 to diagnose cancer and monitor... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2082092